Conor Medsystems

Conor Medsystems to Present at the A.G. Edwards Emerging Growth Conference

MENLO PARK, Calif., Sept. 14 /PRNewswire-FirstCall/ — Conor Medsystems, Inc. (Nasdaq: CONR) is scheduled to present at the A.G. Edwards Emerging Growth Conference on Wednesday, September 20, 2006 in New York. Frank Litvack, M.D., Chairman and CEO, will provide a corporate update at 2:15 p.m. Eastern Time.

To access the live audio broadcast or the subsequent archived recording, visit the webcast section of the company's website located at www.conormed.com . The recording will be archived for 30 days following the live presentation. Please log on to Conor's website several minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary.

About Conor Medsystems
Conor Medsystems, Inc. develops innovative controlled vascular drug delivery technologies, and has initially focused on the development of drug-eluting stents to treat coronary artery disease. For further information on Conor Medsystems and controlled vascular delivery, visit www.conormed.com .

SOURCE Conor Medsystems, Inc.
09/14/2006

CONTACT: investors, Michael Boennighausen, Chief Financial Officer of
Conor Medsystems, Inc., +1-650-614-4100; or media, Karen L. Bergman of BCC
Partners, +1-650-575-1509, for Conor Medsystems, Inc.
Web site: http://www.conormed.com
(CONR)
3209 09/14/2006 18:22 EDT http://www.prnewswire.com